Related Experiment Video
Updated: May 9, 2026

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury
Published on: March 31, 2023
Aortic stenosis: role of balloon aortic valvuloplasty
Usman Baber1, Annapoorna S Kini, Pedro R Moreno
1Cardiac Catheterization Laboratory, Mount Sinai Medical Center, New York, NY 10029, USA.
Insights
Calcific aortic stenosis (AS), a common heart valve disease in older adults, affects nearly 4% of those 75+. Balloon aortic valvuloplasty (BAV) offers symptomatic relief and temporary hemodynamic stabilization for high-risk patients.
Area of Science:
- Cardiology
- Geriatric Medicine
- Valvular Heart Disease
Background:
- Calcific aortic stenosis (AS) is the most prevalent form of aortic valve disease globally.
- Its incidence rises significantly with increasing age, affecting nearly 4% of adults aged 75 and older.
- Many patients with AS are unsuitable for surgery due to comorbidities or high-risk factors.
Purpose of the Study:
- To highlight the role of balloon aortic valvuloplasty (BAV) in managing calcific aortic stenosis.
- To discuss BAV as a palliative measure for symptomatic relief in high-risk patients.
- To explore BAV's utility as a bridge to definitive valve replacement therapies.
Main Methods:
- Review of current clinical practices and literature regarding balloon aortic valvuloplasty for AS.
- Analysis of BAV's efficacy in providing temporary palliation and hemodynamic stabilization.
- Evaluation of BAV's role in the treatment algorithm for severe aortic stenosis in non-surgical candidates.
Main Results:
- Balloon aortic valvuloplasty (BAV) provides temporary symptomatic relief for patients with severe aortic stenosis.
- BAV is a viable option for hemodynamic stabilization in select AS patients.
- It serves as a crucial bridge therapy for patients awaiting surgical or transcatheter valve replacement.
Conclusions:
- Balloon aortic valvuloplasty (BAV) remains an important therapeutic option for calcific aortic stenosis, particularly in elderly and high-risk populations.
- BAV offers palliative benefits and hemodynamic support when surgery is not feasible.
- Its role as a bridge to more definitive treatments is well-established.
Abstract:
Calcific aortic stenosis (AS) is the most frequent expression of aortic valve disease in the Western world, with an increasing prevalence as the population ages. Almost 4% of all adults 75 years of age or older have moderate or severe AS. Many patients do not undergo surgery because of prohibitive comorbidities or other high-risk features. Balloon aortic valvuloplasty (BAV) remains an option for temporary palliation and symptomatic relief in such patients. In addition, BAV continues to serve an important role as a bridge to either surgical or transcatheter aortic valve replacement in certain patients with AS requiring temporary hemodynamic stabilization.
Related Concept Videos
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Mitral Stenosis IV: Nursing Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation IV: Nursing Management
